Healthy Extracts (HYEX) Net Cash Flow Growth (3y) (2018 - 2025)
Healthy Extracts (HYEX) Net Cash Flow Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -62.71% |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -72.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.85% |
| Sep 30, 2025 | 49.46% |
| Jun 30, 2025 | 6.77% |
| Mar 31, 2025 | 27.08% |
| Dec 31, 2024 | -52.29% |
| Sep 30, 2024 | 34.70% |
| Jun 30, 2024 | 4.10% |
| Mar 31, 2024 | -26.90% |
| Dec 31, 2023 | 56.18% |
| Sep 30, 2023 | 45.49% |
| Jun 30, 2023 | -29.93% |
| Mar 31, 2023 | 61.89% |
| Dec 31, 2022 | -31.95% |
| Sep 30, 2022 | 65.82% |
| Jun 30, 2022 | -67.23% |
| Mar 31, 2022 | -33.56% |
| Dec 31, 2021 | 195.17% |
| Sep 30, 2021 | -108.24% |
| Jun 30, 2021 | 35.24% |
| Mar 31, 2021 | 200.55% |